FR92830E - Préparation de nouvelles guanidines, iso-urées et iso-thio-urées douées en particulier d'une activité biologique. - Google Patents

Préparation de nouvelles guanidines, iso-urées et iso-thio-urées douées en particulier d'une activité biologique.

Info

Publication number
FR92830E
FR92830E FR100002A FR100002A FR92830E FR 92830 E FR92830 E FR 92830E FR 100002 A FR100002 A FR 100002A FR 100002 A FR100002 A FR 100002A FR 92830 E FR92830 E FR 92830E
Authority
FR
France
Prior art keywords
iso
thioureas
endowed
ureas
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR100002A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB44453/61A external-priority patent/GB1003889A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to FR111445A priority Critical patent/FR6597M/fr
Application granted granted Critical
Publication of FR92830E publication Critical patent/FR92830E/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44Antibodies bound to carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/42Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR100002A 1961-12-12 1967-03-23 Préparation de nouvelles guanidines, iso-urées et iso-thio-urées douées en particulier d'une activité biologique. Expired FR92830E (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR111445A FR6597M (es) 1961-12-12 1967-06-22

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB44453/61A GB1003889A (en) 1961-12-12 1961-12-12 Guanidines and isothioureas
GB1332266A GB1171619A (en) 1961-12-12 1966-03-25 Vaccine adjuvants

Publications (1)

Publication Number Publication Date
FR92830E true FR92830E (fr) 1969-01-03

Family

ID=26249709

Family Applications (2)

Application Number Title Priority Date Filing Date
FR100002A Expired FR92830E (fr) 1961-12-12 1967-03-23 Préparation de nouvelles guanidines, iso-urées et iso-thio-urées douées en particulier d'une activité biologique.
FR111445A Expired FR6597M (es) 1961-12-12 1967-06-22

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR111445A Expired FR6597M (es) 1961-12-12 1967-06-22

Country Status (4)

Country Link
BE (1) BE696102A (es)
CH (1) CH544742A (es)
FR (2) FR92830E (es)
GB (1) GB1171619A (es)

Also Published As

Publication number Publication date
CH544742A (de) 1974-01-15
BE696102A (es) 1967-09-25
GB1171619A (en) 1969-11-26
FR6597M (es) 1969-01-06

Similar Documents

Publication Publication Date Title
OA01009A (fr) Préparation d'urée.
IT7928417A0 (it) Composizioni farmaceutiche con esaltazione dell'attivita'terapeutica di cortisonici.
FR1234419A (fr) Préparation d'urée
FR1514M (fr) Nouvelles préparations thérapeutiques.
FR2373M (fr) Nouveaux médicaments a base d'enzymes protéolytiques.
FR3597M (fr) Nouvelles préparations a activité d'hormone adrénocorticotrope et leur fabrication.
FR1293557A (fr) Constructions nouvelles à partir d'éléments standard
FR92830E (fr) Préparation de nouvelles guanidines, iso-urées et iso-thio-urées douées en particulier d'une activité biologique.
FR6247M (fr) Nouvelles applications thérapeutiques des épithio-2,3 stéroïdes.
FR3347M (fr) Médicament a activité vitaminique c a base de nouveaux 2,6-diesters d'acide ascorbique.
FR1499104A (fr) Préparation de nouvelles guanidines, iso-urées et iso-thio-urées douées en partiqulier d'une activité biologique
BE617208A (fr) Colorants dérivant de 4-halogéno-4'.4"-diarylamino-triphényl-méthanes dissymétriques et leur préparation
FR1321854A (fr) Composition de catalyseur possédant une acidité active et une activité d'hydrogénation
BE617209A (fr) Colorants dérivant de 4-halogéno-4'.4"-diarylamino-triphénylméthanes symétriques et leur préparation
FR2340M (fr) Suspensions stables et a activité prolongée d'hormone adrénocorticotrope.
OA01109A (fr) Herbicides à base d'urée substituée.
FR2247M (fr) Nouvelles compositions médicamenteuses contre l'aphte.
FR2018M (fr) Composition a activité cardiaque et circulatoire.
BE599006A (fr) Complexe de Werner et sa préparation.
FR2419M (fr) Nouveaux médicaments doués notamment d'activité stathmocinétique.
FR137M (fr) Médicament, ayant en particulier une activité lipotrope et tonique, ? l'ergothionéine.
FR2652M (fr) Nouveau médicament doué notamment d'activité stathmocinétique.
FR2655M (fr) Nouveau médicament doué notamment d'activité stathmocinétique.
FR2870M (fr) Nouveaux médicaments doués notamment d'activité antimitotique.
FR1132440A (fr) Lit, plus particulièrement lit médical avec sommier formé d'éléments articulés inclinables